Skip to main content
OpenTrials

Clinical trial condition

Eosinophilic Asthma

Explore clinical trials studying Eosinophilic Asthma. Study availability and eligibility vary by location and protocol.

20 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Eosinophilic Asthma trial results

Completed

Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma

NCT03469934

Conditions
Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
Locations
  • Midwest Allergy Sinus Asthma Normal, Illinois, United States
  • Pulmonary & Critical Care Specialists Novi, Michigan, United States
  • OK Clinical Research, LLC Edmond, Oklahoma, United States
  • Allergy & Asthma Center of Southern Oregon Medford, Oregon, United States
View Trial Details
Completed

Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma

NCT04046939

Conditions
Asthma, Bronchial Diseases, Eosinophilia, +13 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Mission Viejo, California, United States
  • Research Site Westminster, California, United States
  • Research Site Denver, Colorado, United States
View all 36 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma

NCT01285323

Conditions
Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
Locations
  • Teva Investigational Site 48 Mobile, Alabama, United States
  • Teva Investigational Site 41 Fresno, California, United States
  • Teva Investigational Site 59 Long Beach, California, United States
  • Teva Investigational Site 47 Denver, Colorado, United States
View all 104 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma

NCT01287039

Conditions
Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
Locations
  • Teva Investigational Site 58 Scottsdale, Arizona, United States
  • Teva Investigational Site 61 Los Angeles, California, United States
  • Teva Investigational Site 37 Orange, California, United States
  • Teva Investigational Site 56 San Diego, California, United States
View all 128 locations
View Trial Details
Completed

XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma

NCT04674137

Conditions
Asthma, Bronchial Asthma, Bronchial Diseases, +14 more
Locations
  • Federal State Autonomous Educational Institution of Higher Education "Immanuel Kant Baltic Federal University"of Ministry of Health of the Russian Federation Kaliningrad, Russia
  • Federal State Autonomous Educational Institution of Higher Education "Kazan (Volga region) Federal University" Kazan', Russia
  • Federal State Educational Institution of Higher Education "Kazan State Medical University" of the Ministry of Health of the Russian Federation Kazan', Russia
  • State Budgetary Institution of Healthcare of Moscow "City Clinical Hospital n.a. D.D.Pletnev" of the Moscow Department of Healthcare" Moscow, Russia
View all 18 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma

NCT01508936

Conditions
Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
Locations
  • Investigational Site 861 Birmingham, Alabama, United States
  • Investigational Site 842 Homewood, Alabama, United States
  • Investigational Site 887 Jasper, Alabama, United States
  • Investigational Site 809 Tucson, Arizona, United States
View all 66 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma

NCT01270464

Conditions
Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
Locations
  • Teva Investigational Site 12 Anaheim, California, United States
  • Teva Investigational Site 11 Fountain Valley, California, United States
  • Teva Investigational Site 43 Los Angeles, California, United States
  • Teva Investigational Site 4 Orange, California, United States
View all 89 locations
View Trial Details

Related conditions